Abstract:
Objective To analyze the drug susceptibility of Mycobacterium avium and Mycobacterium intracellulare strains to 15 antibiotics, compare the difference in drug susceptibility between the two species and provide reference for drug resistance surveillance and treatment of M. avium and M. intracellulare infections.
Methods Broth microdilution method was used to analyze the susceptibilities of 144 clinical isolates of M. avium and 20 clinical isolates of M. intracellulare to 15 antibiotics, including clarithromycin, amikacin, moxifloxacin, and rifabutin, and the differences in cross-resistance and drug susceptibility between the two species were compared.
Results M. avium was highly sensitive to amikacin (97.92%, 141/144), tobramycin (97.92%, 141/144), rifabutin (97.92%, 141/144), and clarithromycin (95.83%, 141/144). M. intracellulare was highly sensitive to amikacin (100.00%, 20/20), tobramycin (100.00%, 20/20), rifabutin (100.00%, 20/20), clarithromycin (100.00%, 20/20), streptomycin (100.00%, 20/20), and clofazimine (100.00%, 20/20). M. intracellulare showed significantly higher sensitivity to tigecycline and rifampicin compared with M. avium (χ2=4.983、6.267, P=0.026、0.012).
Conclusion Both M. avium and M. intracellulare were all sensitive to amikacin, tobramycin, rifabutin, clarithromycin and streptomycin. The analysis on the drug susceptibility of the two species can provide reference for the antibiotic selection in the clinical treatment of M. avium and M. intracellulare infections.